Chemoproteomic Profiling Reveals that Anticancer Natural Product Dankastatin B Covalently Targets Mitochondrial VDAC3**
ChemBioChem · 2023
DOI: 10.1002/cbic.202300111 ↗Kurz gefasst
Fachartikel in der Zeitschrift ChemBioChem, 2023. Verfasst von Bridget P Belcher und 9 weiteren Autor:innen. Beteiligte Einrichtung: Department of Chemistry, University of California-Berkeley, Berkeley, CA 94720, USA. Hauptthemen laut MEDLINE: Biological Products, Breast Neoplasms. Die Arbeit wurde bisher 6-mal zitiert (Crossref) und nennt 13 Literaturangaben. Gefördert von: NIH HHS, NCI NIH HHS, National Institutes of Health.
Abstract (Originalsprache)
Chlorinated gymnastatin and dankastatin alkaloids derived from the fungal strain Gymnascella dankaliensis have been reported to possess significant anticancer activity but their mode of action is unknown. These members possess electrophilic functional groups that can might undergo covalent bond formation with specific proteins to exert their biological activity. To better understand the mechanism of action of this class of natural products, we mapped the proteome‐wide cysteine reactivity of the most potent of these alkaloids, dankastatin B, by using activity‐based protein profiling chemoproteomic approaches. We identified a primary target of dankastatin B in breast cancer cells as cysteine C65 of the voltage‐dependent anion‐selective channel on the outer mitochondrial membrane VDAC3. We demonstrated direct and covalent interaction of dankastatin B with VDAC3. VDAC3 knockdown conferred hypersensitivity to dankastatin B‐mediated antiproliferative effects in breast cancer cells, thus indicating that VDAC3 was at least partially involved in the anticancer effects of this natural product. Our study reveals a potential mode of action of dankastatin B through covalent targeting of VDAC3 and highlights the utility of chemoproteomic approaches in gaining mechanistic understanding of electrophilic natural products.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Chemistry, University of California-Berkeley, Berkeley, CA 94720, USA.
- Novartis-Berkeley Translational Chemical Biology Institute, Berkeley, CA 94720, USA.
- Innovative Genomics Institute, Berkeley, CA 94704, USA.
- Department of Molecular and Cell Biology, University of California-Berkeley, Berkeley, CA 94720, USA.
ORCID-Profile: Daniel K Nomura
Förderung
- NIH HHS
- NCI NIH HHS
- National Institutes of Health
- College of Chemistry, Jilin University
Zitieren
APA
Belcher, B. P., Machicao, P. A., Tong, B., Ho, E., Friedli, J., So, B., Bui, H., Isobe, Y., Maimone, T. J., & Nomura, D. K. (2023). Chemoproteomic Profiling Reveals that Anticancer Natural Product Dankastatin B Covalently Targets Mitochondrial VDAC3**. ChemBioChem. https://doi.org/10.1002/cbic.202300111
Vancouver
Belcher BP, Machicao PA, Tong B, Ho E, Friedli J, So B, et al. Chemoproteomic Profiling Reveals that Anticancer Natural Product Dankastatin B Covalently Targets Mitochondrial VDAC3**. ChemBioChem. 2023. doi:10.1002/cbic.202300111
BibTeX
@article{Belcher2023,
author = {Belcher, Bridget P and Machicao, Paulo A and Tong, Binqi and Ho, Emily and Friedli, Julia and So, Brian and Bui, Helen and Isobe, Yosuke and Maimone, Thomas J and Nomura, Daniel K},
title = {Chemoproteomic Profiling Reveals that Anticancer Natural Product Dankastatin B Covalently Targets Mitochondrial VDAC3**},
journal = {ChemBioChem},
year = {2023},
doi = {10.1002/cbic.202300111}
}
EUVIMED